EGFR and esophageal squamous cell carcinoma: Beyond the well-characterized oncogenes and tumor suppressors (EGFR, CDKN2A/2B, CCND1), emerging studies have identified additional genetic regulators (CBX4, ZNF750, CDCA7, FAM84B) that critically contribute to ESCC pathogenesis [4–6].